title: The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models.
abstract: BACKGROUND
  Melanoma is the most deadly form of skin cancer. Expression of oncogenic BRAF or NRAS, which are frequently mutated in human melanomas, promote the formation of nevi but are not sufficient for tumorigenesis. Even with germline mutated p53, these engineered melanomas present with variable onset and pathology, implicating additional somatic mutations in a multi-hit tumorigenic process.
  
  
  RESULTS
  To decipher the genetics of these melanomas, we sequence the protein coding exons of 53 primary melanomas generated from several BRAF(V600E) or NRAS(Q61K) driven transgenic zebrafish lines. We find that engineered zebrafish melanomas show an overall low mutation burden, which has a strong, inverse association with the number of initiating germline drivers. Although tumors reveal distinct mutation spectrums, they show mostly C > T transitions without UV light exposure, and enrichment of mutations in melanogenesis, p53 and MAPK signaling. Importantly, a recurrent amplification occurring with pre-configured drivers BRAF(V600E) and p53-/- suggests a novel path of BRAF cooperativity through the protein kinase A pathway.
  
  
  CONCLUSIONS
  This is the first analysis of a melanoma mutational landscape in the absence of UV light, where tumors manifest with remarkably low mutation burden and high heterogeneity. Genotype specific amplification of protein kinase A in cooperation with BRAF and p53 mutation suggests the involvement of melanogenesis in these tumors. This work is important for defining the spectrum of events in BRAF or NRAS driven melanoma in the absence of UV light, and for informed exploitation of models such as transgenic zebrafish to better understand mechanisms leading to human melanoma formation.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Yen
authors.forename: Richard M
authors.initials: RM
authors.lastname: White
authors.forename: David C
authors.initials: DC
authors.lastname: Wedge
authors.forename: Peter
authors.initials: P
authors.lastname: Van Loo
authors.forename: Jeroen
authors.initials: J
authors.lastname: de Ridder
authors.forename: Amy
authors.initials: A
authors.lastname: Capper
authors.forename: Jennifer
authors.initials: J
authors.lastname: Richardson
authors.forename: David
authors.initials: D
authors.lastname: Jones
authors.forename: Keiran
authors.initials: K
authors.lastname: Raine
authors.forename: Ian R
authors.initials: IR
authors.lastname: Watson
authors.forename: Chang-Jiun
authors.initials: CJ
authors.lastname: Wu
authors.forename: Jiqiu
authors.initials: J
authors.lastname: Cheng
authors.forename: Iñigo
authors.initials: I
authors.lastname: Martincorena
authors.forename: Serena
authors.initials: S
authors.lastname: Nik-Zainal
authors.forename: Laura
authors.initials: L
authors.lastname: Mudie
authors.forename: Yves
authors.initials: Y
authors.lastname: Moreau
authors.forename: John
authors.initials: J
authors.lastname: Marshall
authors.forename: Manasa
authors.initials: M
authors.lastname: Ramakrishna
authors.forename: Patrick
authors.initials: P
authors.lastname: Tarpey
authors.forename: Adam
authors.initials: A
authors.lastname: Shlien
authors.forename: Ian
authors.initials: I
authors.lastname: Whitmore
authors.forename: Steve
authors.initials: S
authors.lastname: Gamble
authors.forename: Calli
authors.initials: C
authors.lastname: Latimer
authors.forename: Erin
authors.initials: E
authors.lastname: Langdon
authors.forename: Charles
authors.initials: C
authors.lastname: Kaufman
authors.forename: Mike
authors.initials: M
authors.lastname: Dovey
authors.forename: Alison
authors.initials: A
authors.lastname: Taylor
authors.forename: Andy
authors.initials: A
authors.lastname: Menzies
authors.forename: Stuart
authors.initials: S
authors.lastname: McLaren
authors.forename: Sarah
authors.initials: S
authors.lastname: O'Meara
authors.forename: Adam
authors.initials: A
authors.lastname: Butler
authors.forename: Jon
authors.initials: J
authors.lastname: Teague
authors.forename: James
authors.initials: J
authors.lastname: Lister
authors.forename: Lynda
authors.initials: L
authors.lastname: Chin
authors.forename: Peter
authors.initials: P
authors.lastname: Campbell
authors.forename: David J
authors.initials: DJ
authors.lastname: Adams
authors.forename: Leonard I
authors.initials: LI
authors.lastname: Zon
authors.forename: E Elizabeth
authors.initials: EE
authors.lastname: Patton
authors.forename: Derek L
authors.initials: DL
authors.lastname: Stemple
authors.forename: P Andy
authors.initials: PA
authors.lastname: Futreal
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D056915:DNA Copy Number Variations; D004195:Disease Models, Animal; D005784:Gene Amplification; D055786:Gene Knockout Techniques; D018740:Genetic Heterogeneity; D006720:Homozygote; D054643:INDEL Mutation; D008545:Melanoma / Q000235:genetics* / Q000473:pathology; D009154:Mutation / Q000528:radiation effects; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D017384:Sequence Deletion; D014466:Ultraviolet Rays; D015027:Zebrafish / Q000235:genetics*